InterWest Venture Management’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,404,515
Closed -$381K 8
2022
Q3
$381K Hold
1,404,515
1.17% 6
2022
Q2
$1.08M Hold
1,404,515
2.01% 6
2022
Q1
$1.5M Hold
1,404,515
0.57% 7
2021
Q4
$2.67M Hold
1,404,515
1.58% 7
2021
Q3
$4.23M Hold
1,404,515
1.75% 7
2021
Q2
$5.49M Hold
1,404,515
1.73% 6
2021
Q1
$7.12M Hold
1,404,515
1.87% 5
2020
Q4
$5.74M Sell
1,404,515
-51,389
-4% -$252K 0.72% 8
2020
Q3
$7.08M Hold
1,455,904
2.04% 4
2020
Q2
$8.07M Hold
1,455,904
6.69% 3
2020
Q1
$4.78M Hold
1,455,904
5.05% 5
2019
Q4
$6.58M Hold
1,455,904
2.84% 6
2019
Q3
$6.06M Hold
1,455,904
2.32% 6
2019
Q2
$5.52M Hold
1,455,904
1.78% 7
2019
Q1
$6.1M Hold
1,455,904
5.6% 6
2018
Q4
$3.63M Hold
1,455,904
5.09% 6
2018
Q3
$10.6M Hold
1,455,904
5.19% 6
2018
Q2
$5.39M Hold
1,455,904
2.28% 8
2018
Q1
$5.61M Hold
1,455,904
2.36% 7
2017
Q4
$5.24M Hold
1,455,904
1.79% 9
2017
Q3
$5.75M Hold
1,455,904
1.5% 8
2017
Q2
$7.42M Buy
1,455,904
+3,688
+0.3% +$20.7K 1.76% 9
2017
Q1
$10M Hold
1,452,216
2.13% 7
2016
Q4
$13.6M Buy
+1,452,216
New +$13.1M 3.24% 7

InterWest Venture Management's AGTC Position: Q4 2022 in Review

InterWest Venture Management sold out of Applied Genetic Technologies Corporation (AGTC) in Q4 2022, closing a stake of 1,404,515 shares — an estimated $381K sold.

InterWest Venture Management first reported a position in AGTC in Q4 2016 and held it in 24 quarters. The position peaked at $13.6M in Q4 2016. 0 funds tracked by Wall St. Rank hold AGTC as of Q4 2022.

  • InterWest Venture Management reported no remaining Applied Genetic Technologies Corporation position as of Q4 2022 after selling out during the quarter.
  • InterWest Venture Management sold 1,404,515 Applied Genetic Technologies Corporation shares in Q4 2022, an estimated $381K.
  • InterWest Venture Management first reported a position in Applied Genetic Technologies Corporation in Q4 2016 and held it in 24 quarters.
  • InterWest Venture Management's Applied Genetic Technologies Corporation position peaked at $13.6M in Q4 2016.
  • 0 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q4 2022.

Based on InterWest Venture Management's 13F filing for Q4 2022, filed 31 Jan 2023.